Charleston Laboratories, Inc. and Daiichi Sankyo, Inc. Receive Complete Response Letter from FDA for NDA for CL-108 (hydrocodone, acetaminophen, promethazine) Tablets

JUPITER, Fla., and PARSIPPANY, N.J., Feb. 3, 2017 /PRNewswire/ -- Charleston Laboratories, Inc., and Daiichi Sankyo, Inc., confirmed today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news